Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotech company focused on developing precision medicines for neurological and psychiatric conditions, announced that its leadership team will be participating in two major investor conferences this June.
Jefferies Global Healthcare Conference
Goldman Sachs 46th Annual Global Healthcare Conference
Anyone interested in tuning in can access live and recorded webcasts of both events through the “Investors” section of Rapport’s website: https://investors.rapportrx.com